Cap Alpha is a Venture Capital firm that was founded in January 2012 in Hong Kong, originally with a focus on investing in local startups. Sensing the region’s great potential for growth, in mid-2014 we began operations in Southeast Asia and established strong relations with partners in Singapore, Malaysia and Thailand.
Our current activities mainly consist of venture investment and support in Southeast Asia, Hong Kong and since March 2015, we extended our operations in Republic of Korea.
Taking a bottom-up approach to management and emphasizing integrity and commitment, we aspire to utilize our rich knowledge that we have acquired from our experience in the field to contribute to the growth of startups in Asia. In addition, we aim to use our expertise to spur innovation in all projects in which we are involved.
With wide-ranging expertise spanning business strategy, human resources, product development, marketing, and finance, Cap Alpha provides the support necessary for startups to realize their high potential.
At Cap Alpha, we aim to build a bridge between investors and innovative asian startups.
Company Details
- Founded
- -
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.capalphasia.com
- Keywords
- Venture Capital, Fundraising, Startups.
- Competitors
- OXELTIS, AZELEAD, ALPHA MÉCANIQUE sarl, PRADO Preclinical Research and Development Organization Pvt. Ltd. (Official), ACOBIOM, Phost'in Therapeutics, PredictCan Biotechnologies, UNT Capital, Institut des Sciences de l'Evolution de Montpellier (ISEM), IRCM - Institut de Recherche en Cancérologie de Montpellier.
Cap Alpha Questions
Cap Alpha's website is http://www.capalphasia.com
Cap Alpha's LinkedIn profile is https://www.linkedin.com/company/cap-alpha
Cap Alpha's industry is
Venture Capital and Private Equity Principals
Cap Alpha's top competitors are
Oxeltis,
Azelead,
Alpha Mécanique Sarl,
Prado Preclinical Research And Development Organization Pvt. Ltd. (Official),
Acobiom,
Phost'in Therapeutics,
Predictcan Biotechnologies,
Unt Capital,
Institut Des Sciences De L'evolution De Montpellier (Isem),
Ircm - Institut De Recherche En Cancérologie De Montpellier.
Cap Alpha's categories are Venture Capital and Private Equity Principals
Cap Alpha's founding year is 2012
